Andersen, Andreas

Glucagon-like peptide 1 in health and disease

Andersen, A., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Nature Reviews Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 543

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

Seghieri, M., Christensen, A. S., Andersen, A., Solini, A., Knop, F. K., & Vilsbøll, T. (2018) · Frontiers in Endocrinology

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 92

How glucagon-like peptide 1 receptor agonists work

Andreasen, C. R., Andersen, A., Knop, F. K., & Vilsbøll, T. (2021) · Endocrine Connections

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 71

The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease

Andreasen, C. R., Andersen, A., & Vilsbøll, T. (2023) · Diabetologia

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 44

Cardiovascular biomarkers in clinical studies of type 2 diabetes

Baldassarre, M. P. A., Andersen, A., Consoli, A., Knop, F. K., & Vilsbøll, T. (2018) · Diabetes, Obesity and Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 22